
In Vitro Diagnostics Business Outlook, Volume 3, Issue 2
Description
In Vitro Diagnostics Business Outlook, Volume 3, Issue 2 - Focus on Immunoassay Overview
ISSUE 2 OF 6 - In Vitro Diagnostics Business Outlook, Volume 3, Issue 2 - Focus on Immunoassay
(price includes 6 issues published every two months)In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.
In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including:
Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities
- A comprehensive view of the IVD market with test categories covered and company briefs
- M&A activities, selected partnerships & collaborations, partnership deals, and more
- Industry & region watch to help tailor strategies
- Analysis of news and events and reporting on news not easily available
Table of Contents
34 Pages
- MARKET ANALYSIS
- OVERVIEW OF IVD IMMUNOASSAY
- MARKET OUTLOOK
- Table: Global Lab-Based Immunoassay Market by Segment, 2023-2028 ($ millions)
- Figure: Global Lab-Based Immunoassay Market, by Segment, 2023-2028 ($ millions)
- REGIONAL MARKET
- Table: Global Immunoassay Market (Lab-Based) Sales Distribution, by Region, 2023 (%) (North America, Europe, Asia Pacific, Latin America, Middle East, Africa)
- Figure: Global Immunoassay Market Sales Distribution, Top 10 Country Markets, 2023 (%)
- TOP COMPANY BRIEFS
- Roche
- Abbott Diagnostics
- Siemens Healthineers
- Other Selected Immunoassay News
- EXECUTIVE NEWS BRIEFING
- NOWDIAGNOSTICS SELECTS NEW SCIENCE OFFICER
- FREENOME RAISES $254 MILLION IN NEW FUNDING
- QUIDELORTHO AXES CEO
- AGILENT CEO TO RETIRE
- FINANCIAL HIGHLIGHTS: BIO-RAD LABORATORIES AND VERACYTE
- BIO-RAD LABORATORIES REPORTS FULL-YEAR 2023 CLINICAL DIAGNOSTICS REVENUES UP 3.2% OVER PREVIOUS YEAR
- Table: Bio-Rad Laboratories Net Sales, 2021-2023 ($M)
- Figure: Bio-Rad Laboratories’ Sales by Business, 2022 vs. 2023, $M
- Figure: Bio-Rad Laboratories Quarterly Performance by Business, 2022 vs. 2023 ($M)
- Figure: Bio-Rad Laboratories 2022 and 2023 Regional Sales Breakdown Distribution
- VERACYTE REPORTED STRONG PERFORMANCE IN 2023
- Figure: Veracyte 12-Month (FY22 and FY23) Sales by Division (Testing, Product, Biopharmaceutical and Other), Thousands USD
- DIAGNOSTIC MARKET MERGERS, ACQUISITIONS AND PARTNERSHIP DEALS
- MERGERS AND ACQUISITIONS
- Table: Selected Diagnostic Market Mergers and Acquisitions Deals
- PARTNERSHIPS AND COLLABORATIONS
- INDUSTRY WATCH
- VIRUS TESTING UPDATE
- REGION WATCH
- PERU
- Figure: Peru Population Distribution by Broad Age Group, 2023 and 2040 Estimates
- Figure: Peru GDP Value and Growth by Year, 2010-2022
- Figure: Peru COVID-19 Lab Samples Tested and Positivity by Region, Cumulative 2020-2023
- SOUTH AFRICA
- Figure: South Africa Population Pyramid, 2023 and 2033 Estimates
- Figure: South Africa GDP, Composition by Sector (Agriculture, Industry, Services)
- BROAD-BASED COMPANY ANNOUNCEMENTS
- WERFEN RECEIVES CE MARK FOR APTIVA ANTIPHOSPHOLIPID SYNDROME
- DIASORIN NABS FDA CLEARANCE FOR NEW LIAISON PLEX SYSTEM
- T2 BIOSYSTEMS OFFERS EXPANDED PANEL
- CEPHEID RECEIVED FDA CLEARANCE FOR XPERT XPRESS GBS
- DIACARTA COLLABORATION TO LAUNCH PROSTATE CANCER LDT
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.